Hyperbaric oxygen upregulates cochlear constitutive nitric oxide synthase

BACKGROUND: Hyperbaric oxygen therapy (HBOT) is a known adjuvant for treating ischemia-related inner ear diseases. Controversies still exist in the role of HBOT in cochlear diseases. Few studies to date have investigated the cellular changes that occur in inner ears after HBOT. Nitric oxide, which i...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Lin, Chia-Der, Wei, I-Hua, Lai, Chih-Ho, Hsia, Te-Chun, Kao, Ming-Ching, Tsai, Ming-Hsui, Wu, Ching-Hsiang, Tsai, Mang-Hung
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2011
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3050772/
https://ncbi.nlm.nih.gov/pubmed/21342510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2202-12-21
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires